Hanson & Doremus Investment Management’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
FA
CFD
BFS
II
OFS
PFG
PAW
UCFA
Hanson & Doremus Investment Management's IBD Position: Q2 2026 in Review
Hanson & Doremus Investment Management increased its Inspire Corporate Bond ETF (IBD) stake by 259% in Q2 2026, buying an estimated $397K and bringing the position to 23,092 shares worth $549K. The position accounts for 0.06% of the portfolio, ranked #125.
Hanson & Doremus Investment Management first reported a position in IBD in Q3 2025 and has held it in 4 quarters since. 110 funds tracked by Wall St. Rank hold IBD as of Q2 2026.
- Hanson & Doremus Investment Management held 23,092 shares of Inspire Corporate Bond ETF worth $549K as of Q2 2026.
- Hanson & Doremus Investment Management bought 16,657 Inspire Corporate Bond ETF shares in Q2 2026, an estimated $397K.
- Inspire Corporate Bond ETF made up 0.06% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #125 holding.
- Hanson & Doremus Investment Management first reported a position in Inspire Corporate Bond ETF in Q3 2025 and has held it in 4 quarters since.
- 110 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.